Unlock instant, AI-driven research and patent intelligence for your innovation.
Application of Stat3, HBx and Stat3-HBx target CRISPR/Cas carriers to preparation of HBV-related liver cancer drugs
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A carrier, targeting technology, applied in the field of genetic engineering, can solve problems such as
Active Publication Date: 2020-01-07
SHANDONG UNIV
View PDF1 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, there is currently no high-efficiency vector for the Stat3 target, and a gene knockout product that can simultaneously knock out the two targets of Stat3-HBx
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0094] Example 1: Construction of single-function silencing vectors targeting Stat3 and HBx respectively
[0095] Select the PX333 vector, digest it with BsaⅠ, and recover the linear fragment through agarose gel. According to the design strategy of CRISPR / Cas9 sgRNA, design 3 sgRNAs for the second and eighth exons of Stat3; for the gene sequence of HBx Design 2 sgRNAs (Table 1). The sgRNA fragments were annealed, ligated with the recovered fragments of the PX333 vector by T4 ligase, transformed into competent cells, and single clones were selected for sequencing. Sequencing results showed that 3 kinds of monofunctional plasmids targeting Stat3 and 2 kinds of targeting HBx were successfully constructed.
[0096] Table 1: sgRNA information
[0097]
[0098]
Embodiment 2
[0099] Example 2: Screening of a single-function silencing vector targeting Stat3
[0100] (1) Both Stat3-sgRNA1 and Stat3-sgRNA2 can reduce the expression of Stat3 protein
[0102] Result: as attached figure 2 As shown, the results show that targeting both Stat3-sgRNA1 and sgRNA2 sequences can reduce the expression of Stat3 protein.
[0103] (2) Stat3-sgRNA1 and Stat3-sgRNA2 inhibit the proliferation of HepG2.2.15 cells
[0104] Methods: MTT and living cell monitor were used to study the proliferation of HepG2.2.15 cells after transfection of Stat3 plasmid.
[0105] Results: MTT results showed that targeting the Stat3-sgRNA1 sequence could inhib...
Embodiment 3
[0131] Example 3: Screening of HBx-targeting monofunctional silencing vectors
[0132] HBx-sgRNA2 inhibits the expression of HBx protein
[0133] Method: HepG2.2.15 cells use liposome Lipo6000 as transfection reagent, set ctrl control, lipo6000 control (transfection reagent only), PX333 (vector control), and two plasmid vectors constructed to silence HBx, and transfect After 48 hours, the protein was extracted, and the expression of HBx, p-Stat3, and Stat3 proteins were detected by Western Blot. The results are shown in the attached Figure 8 shown.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a Stat3 target CRISPR / Cas carrier, a Stat3-HBx dual-target CRISPR / Cas carrier, and two repeated-target CRISPR / Cas carriers targeting HBx, and particularly relates to an Stat3 target single-function plasmid, an Stat3-HBx dual-target CRISPR / Cas carrier, two CRISPR / Cas carriers repeatedly targeting the HBx, and a construction method of the carriers. Through tests, the inventorproves that the constructed carriers have a specific target treatment effect on HBV-related liver cancer cells, and the silent gene carrier, the carrier construction method, double-silence strategiesof the carriers for Stat3 and the HBx and application of the carriers to preparation of HBV chronic infection and anti-liver cancer related drugs are within the scope of right protection correspondingly.
Description
technical field [0001] The invention belongs to the technical field of genetic engineering, and specifically relates to the application of Stat3 and HBx target gene CRISPR / Cas silencing vectors in inhibiting HBV chronic infection and treating HBV-related liver cancer. Background technique [0002] Hepatocellular carcinoma is one of the five most common cancers in the world and ranks the third cause of cancer death. In clinical treatment, the five-year survival rate of liver cancer patients is only about 10%. According to the latest 2015 Chinese cancer statistics, liver cancer is the most common cancer diagnosed before the age of 60, and accounts for the first cancer death rate in men, followed by lung cancer and stomach cancer. HBV infection has been considered as an important risk factor for HCC. In many tumors such as liver cancer, there is abnormal expression and persistent activation of signal transducers and activators of transcription 3 (STAT3), and its target genes i...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.